Nasdaq
$11.90▼ 0.08%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $925.4MShares out 77.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
12- 1d agoAfter-hours26.10.24 05:0110-QEarnings#●●●#●●●
INTEGRA LIFESCIENCES HOLDINGS CORP
Integra LifeSciences Holdings Corporation has filed its 10-Q quarterly report for the period ending September 30, 2026, with certifications from its principal executive and financial officers. The filing includes detailed terms regarding restricted stock unit (RSU) awards and non-qualified stock option agreements under the company's equity incentive plan.…more
$11.90-0.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 4d agoPre-market26.10.21 19:158-KKey event
INTEGRA LIFESCIENCES HOLDINGS CORP
Integra LifeSciences reported third-quarter 2026 revenue of $411.2 million and GAAP net income of $14.9 million ($0.19 per diluted share). Despite an approximate $7 million revenue impact from flood damage at its Cincinnati facility, the company completed a $2.1 billion debt refinancing to enhance financial flexibility.…more
$11.90-0.08%vs prev closeView filingShare - 5d agoAfter-hours26.10.20 05:208-KKey event
INTEGRA LIFESCIENCES HOLDINGS CORP
On October 19, 2026, Integra LifeSciences completed a private offering of $450 million in 9.5% senior secured notes due 2033 and entered into a new $1.65 billion credit agreement. The proceeds were used to fully repay and refinance the company's existing credit facility.…more
$11.90-0.08%vs prev closeView filingShare
11 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 4d agoPre-market26.10.21 19:01Bullish#●●●
Integra Lifesciences Q4 Guidance Misses Estimates
Integra Lifesciences issued Q4 adjusted EPS and revenue guidance that fell short of analyst expectations. The weaker-than-expected outlook suggests potential downward pressure on the stock.…more
$11.90-0.08%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 5d agoAfter-hours26.10.20 05:05
●●●●●●●● ●●●●● ●●●●●●
Integra LifeSciences has successfully closed a $450 million senior secured notes offering and amended its existing $1.65 billion credit facility. The proceeds were used to refinance existing debt and optimize the company's capital structure.…more
$11.90-0.08%vs prev close - 10.16Pre-market26.10.16 21:39
●●●●●●●● ●●●●● ●●●●●●
Integra LifeSciences will highlight its ENT technology portfolio and sponsor clinical research presentations at the upcoming AAO-HNSF annual meeting. This participation serves as a marketing and educational initiative rather than a material financial event.…more
$11.90-0.08%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report